Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. allergic reactions
Show results for
Products
Services
Training
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Allergic Reactions Articles & Analysis: Older

58 news found

Pet Allergen Exposures in Homes and Buildings across Puerto Rico

Pet Allergen Exposures in Homes and Buildings across Puerto Rico

Both furry pets and those with feathers can cause an allergic reaction in some people. Pet dander is a significant source of pet allergens and is composed of proteins from flecks of skin shed by pets. ...

ByCochrane & Associates, LLC


Mitigating Fusarium Exposure and Infection Risks in Hospitals and Buildings throughout Puerto Rico

Mitigating Fusarium Exposure and Infection Risks in Hospitals and Buildings throughout Puerto Rico

Exposure to elevated levels of it, as with other types of fungi, may cause allergic reactions in some people or it can act as a respiratory irritant. ...

ByCochrane & Associates, LLC


CD Formulation Newly Launches Dissolving Microneedle Preparation Services: Enhancing Drug Delivery Efficiency   

CD Formulation Newly Launches Dissolving Microneedle Preparation Services: Enhancing Drug Delivery Efficiency  

The company adheres to stringent quality control measures and uses biocompatible materials to prevent adverse reactions. Additionally, CD Formulation's dissolving microneedles are designed to degrade and dissolve completely, leaving no residue in the skin, and reducing the risk of infection or allergic reactions. ...

ByCD Formulation


Understanding the Connection between Hay Fever and Snoring

Understanding the Connection between Hay Fever and Snoring

As we move towards the New Year, we’ll be anxiously awaiting the warming days of springtime. Well, most of us will anyway. Fortunately for many of us, and unfortunately for many others, it means flowers will be in bloom after spring rains and some of us will be suffering with seasonal allergic rhinitis, more commonly referred to as hay fever. It’s all about the coughing, the red ...

ByTannerMedico A/S - Asonor


Mold is a Common Asthma Trigger in Puerto Rico and Resources to Mitigate Exposure Risks

Mold is a Common Asthma Trigger in Puerto Rico and Resources to Mitigate Exposure Risks

Not only can mold trigger asthma attacks in some people with the disease, inhaling or touching mold may cause allergic reactions in sensitive individuals. These allergic reactions are quite common and can be immediate or delayed. ...

ByCochrane & Associates, LLC


VBI Vaccines Secures $100 Million Debt Facility From K2 HealthVentures

VBI Vaccines Secures $100 Million Debt Facility From K2 HealthVentures

Important Safety Information (ISI) Do not administer PreHevbrio to individuals with a history of severe allergic reaction (e.g. anaphylaxis) after a previous dose of any hepatitis B vaccine or to any component of PreHevbrio. Appropriate medical treatment and supervision must be available to manage possible anaphylactic reactions following ...

ByVBI Vaccines Inc.


Possible Side Effects of Local Anesthesia

Possible Side Effects of Local Anesthesia

In fact, this older group has some unique risk factors, being more prone to aspiration, pressure ulcers, and adverse drug reactions. Here are some of the side effects experienced in most average adults: Dry mouth: This is common after receiving anesthetics. You may also be nauseated, so make sure to sip water slowly, instead of drinking quickly. ...

ByMilestone Scientific, Inc.


Valneva and VBI Vaccines Announce European Partnership for Marketing and Distribution of PreHevbri

Valneva and VBI Vaccines Announce European Partnership for Marketing and Distribution of PreHevbri

Important Safety Information (ISI) Do not administer PreHevbrio to individuals with a history of severe allergic reaction (e.g. anaphylaxis) after a previous dose of any hepatitis B vaccine or to any component of PreHevbrio. Appropriate medical treatment and supervision must be available to manage possible anaphylactic reactions following ...

ByVBI Vaccines Inc.


VBI Vaccines Announces Appointment of John Dillman as Chief Commercial Officer

VBI Vaccines Announces Appointment of John Dillman as Chief Commercial Officer

Important Safety Information (ISI) Do not administer PreHevbrio to individuals with a history of severe allergic reaction (e.g. anaphylaxis) after a previous dose of any hepatitis B vaccine or to any component of PreHevbrio. Appropriate medical treatment and supervision must be available to manage possible anaphylactic reactions following ...

ByVBI Vaccines Inc.


VBI Vaccines Announces New Long-Term Follow-Up Clinical Data for its 3-Antigen Adult Hepatitis B Vaccine Presented at EASL 2022

VBI Vaccines Announces New Long-Term Follow-Up Clinical Data for its 3-Antigen Adult Hepatitis B Vaccine Presented at EASL 2022

Important Safety Information (ISI) Do not administer PreHevbrio to individuals with a history of severe allergic reaction (e.g. anaphylaxis) after a previous dose of any hepatitis B vaccine or to any component of PreHevbrio. Appropriate medical treatment and supervision must be available to manage possible anaphylactic reactions following ...

ByVBI Vaccines Inc.


VBI Vaccines Announces Abstract Accepted for Oral Presentation at EASL 2022

VBI Vaccines Announces Abstract Accepted for Oral Presentation at EASL 2022

Important Safety Information (ISI) Do not administer PreHevbrio to individuals with a history of severe allergic reaction (e.g. anaphylaxis) after a previous dose of any hepatitis B vaccine or to any component of PreHevbrio. Appropriate medical treatment and supervision must be available to manage possible anaphylactic reactions following ...

ByVBI Vaccines Inc.


The Essential Guide to Food Allergies

The Essential Guide to Food Allergies

Toddlers often have more severe reactions, displaying all symptoms of an allergic reaction including vomiting. ...

ByHYCOR Biomedical


Covid-19 or Seasonal Allergy: How to differentiate?

Covid-19 or Seasonal Allergy: How to differentiate?

Take a close look at your tissue after you blow your nose. Generally, with allergic reactions, your mucus is very often clear and runny whereas with more serious infections it might be thicker and discolored. ...

ByHYCOR Biomedical


Hidden Allergens in Christmas meals

Hidden Allergens in Christmas meals

This Christmas season, when families gather together and consume tasty holiday foods, it is essential to be aware of allergic reactions, which usually increase during this period. Food allergies are estimated to affect 1% to 10% of adults and children in developed countries[1]. ...

ByHYCOR Biomedical


Dupixent (dupilumab) Approved by European Commission for Children Aged 6 to 11 Years with Severe Asthma with Type 2 Inflammation

Dupixent (dupilumab) Approved by European Commission for Children Aged 6 to 11 Years with Severe Asthma with Type 2 Inflammation

In addition to the currently approved indications, Regeneron and Sanofi are studying dupilumab in a broad range of diseases driven by type 2 inflammation or other allergic processes including pediatric atopic dermatitis (6 months to 5 years of age, Phase 3), chronic obstructive pulmonary disease with evidence of type 2 inflammation (Phase 3), eosinophilic esophagitis (Phase 3), ...

ByRegeneron Pharmaceuticals Inc.


FDA Accepts Dupixent (dupilumab) for Priority Review in Patients Aged 12 Years and Older with Eosinophilic Esophagitis

FDA Accepts Dupixent (dupilumab) for Priority Review in Patients Aged 12 Years and Older with Eosinophilic Esophagitis

In addition to the currently approved indications, Regeneron and Sanofi are studying dupilumab in a broad range of diseases driven by type 2 inflammation or other allergic processes, including eosinophilic esophagitis (Phase 3), pediatric atopic dermatitis (6 months to 5 years of age, Phase 3), chronic rhinosinusitis without nasal polyposis (Phase 3), chronic obstructive ...

ByRegeneron Pharmaceuticals Inc.


INT301 Continues to Meet Safety Goals in Phase 1 OMEGA Study in Adults with Peanut Allergy While Reaching Phase 2 Target Maintenance Dose

INT301 Continues to Meet Safety Goals in Phase 1 OMEGA Study in Adults with Peanut Allergy While Reaching Phase 2 Target Maintenance Dose

“Patients suffering from peanut allergy are often concerned about the possibility of a severe allergic reaction caused by exposure to these foods. There continues to be a high unmet need for treatment options to help patients live their lives with less fear, and the progression of this study of INT301 is extremely encouraging,” said William Berger, ...

ByIntrommune Therapeutics


Pollen, Mold and Other Indoor Contaminants Impact Puerto Rico’s Allergy and Asthma Rates

Pollen, Mold and Other Indoor Contaminants Impact Puerto Rico’s Allergy and Asthma Rates

For anyone exposed to pollen, it can cause various symptoms, or none at all. For those allergic to pollen, the Centers for Disease Control and Prevention (CDC) reports that exposure can trigger various allergic reactions, including symptoms of hay fever. ...

ByCochrane & Associates, LLC


Profacgen Launched Antibiotic-free Expression System for Protein Expression Service

Profacgen Launched Antibiotic-free Expression System for Protein Expression Service

However, antibiotic residues in protein products often cause allergic reactions in the body, while the widespread use of resistance genes leads to the emergence of more and more resistant strains in the environment. ...

ByProfacgen


Bristol Myers Squibb (NYSE: BMY) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen

Bristol Myers Squibb (NYSE: BMY) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen

Adverse reactions occurred in 55 patients out of 62 treated with Abecma in the CRB-401 trial. ...

ByBristol Myers Squibb Corporate

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT